The pharma giant has invested in the clinical trial exploring the viability of Vedanta Biosciences’ VE202 inflammatory bowel disease treatment candidate.
in-PharmaTechnologist.com presents its latest round up of executive moves in the pharma sector, including appointments at Sanofi, Amylin, Lophius Biosciences, Lophius, Adventrx, BioSante and Medicure.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Discovery Laboratories, Eli Lilly and Agios Pharmaceuticals.
in-PharmaTechnologist presents its latest round up of movements in the sector, including appointments at Pfizer, Biocodex, Unigene, Pieris and Progenics.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including appointments at Baxter, Dendreon, Roche, Somaxon and Silence Therapeutics.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including the retirement of Biogen Idec’s CEO and appointments at Dishman and Noven.
in-PharmaTechnologist presents its latest round up of movements in the pharma sector, including Novartis’ former CEO joining Amylin’s board and an appointment at OctoPlus.
According to a latest report, the growth of the biotechnology
company will continue to outpace that of pharmaceutical companies,
with the seven largest biotechnology companies growing at rates
faster than the pharmaceutical industry's...